We observed that inhibition of LPLA2 strongly correlates with drugs reported to cause phospholipidosis and have identified drugs that have not previously known to cause phospholipidosis, not all of which are cationic amphiphiles. This evidence concerns the gene PLA2G15 and lysosomal storage disease.